0 %

GeneFoxCub
Web-based interpretation software for molecular newborn screening

Import your qPCR runs, review suggested results, and release validated reports - with full traceability from analyser to LIS.

Access to GenefoxCub Access to GenefoxCub

GeneFoxCub is a CE-IVD web-based software that supports the interpretation of molecular newborn screening results generated with LaCAR kits. It captures the run file from your analyser, displays the amplification data in both graphical and tabular form, and proposes a suggested result for each sample based on kit-specific criteria. The clinician reviews the curves and validates each result before release. Every action is recorded, and results can be exported in multiple formats or transferred automatically to your laboratory information system.

No installation required - GeneFoxCub runs in your browser.

WHAT IT IS

Regulatory status: CE-IVDR

Type: Web-based In Vitro Diagnostic Medical Device Software

Intended use: Semi-automatic interpretation support for molecular analysis using LaCAR kits, in professional diagnostic laboratories

Access: Browser-based (Google Chrome, Mozilla Firefox, Edge)

Compatible instruments: LightCycler 480 II (Roche); Cobas z480 (Roche); QuantStudio 1, 3, 5, 6, 7 (Thermo Fisher); CFX96 and CFX Opus 96 Dx (Bio-Rad)

Export formats: PDF, Excel (.xlsx), text (.csv)

LIS integration: Automatic result transfer

Custom cut-off: Lab-defined cut-off configuration per kit (≥ manufacturer LOQ)

Traceability: Every interpretation, edit, comment and approval stamped with user, date, time and software version

General information

Key Features

icon complementary
Lab-defined cut-offs and templates
icon convenient
Direct LIS connection
icon comprehensive
Guided result interpretation
icon user-friendly
Clinician validation built in

  1. Import select your analyser and load the run file.
  2. Configure assign kit, lot and sample type to each well (or load a saved template).
  3. Review GeneFoxCub displays the curves and a suggested result per sample; inspect each channel and CT range.
  4. Validate submit for approval; the responsible clinician approves or rejects after visual control.
  5. Release export as PDF, Excel or CSV, and transfer to your LIS automatically or manually.

HOW IT WORKS

Complete solution for molecular screening

LaCar
Spinal Muscular Atrophy & Severe Combined Immunodeficiency
The NEONATAL SCID&SMA Screening qPCR Flex kit is an assay intended for the semi-quantitative determination of TREC, aiding in the screening of newborns for Severe Combined Immunodeficiency (SCID), and for the qualitative detection of the SMN1 gene (Exon 7), aiding in the screening of newborns for Spinal Muscular Atrophy (SMA).
NEO-M-200
Automated platform for SMA and SCID newborn screening by qPCR (2 plates capacity).
NEO-M-300
Automated platform for SMA and SCID newborn screening by qPCR (3 plates capacity).

You have a question regarding our products ? You want to know more about our method ?

Research and Development

Our vision

At LaCAR, we envision a world where everyone benefits from rapid and reliable genetic diagnostics, enabling personalised healthcare while contributing to more equitable and sustainable global public health.

Aware of these challenges, our R&D team is committed to meeting the needs of customers and patients, taking into account the specific recommendations of different countries and continents, as well as advances in academic research and technology.

Contact